EISAI INC. for EISAI INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 1625 Consolidated Appropriations Act of 2018 -- Inclusion of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Copyright/Patent/Trademark CPT
Amicus petition for certiori in Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries, Ltd.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Health Issues HCR
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Medicare/Medicaid MMM
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.